Latest Biotechnology, Pharmaceutical and Healthcare News from PharmaBiz

18:13 EST 20th January 2019 | BioPortfolio

Here are the most relevant search results for "PharmaBiz" found in our extensive news archives from over 250 global news sources.

More Information about PharmaBiz on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PharmaBiz for you to read. Along with our medical data and news we also list PharmaBiz Clinical Trials, which are updated daily. BioPortfolio also has a large database of PharmaBiz Companies for you to search.

Showing News Articles 1–25 of 1,000+ from PharmaBiz

Saturday 19th January 2019

Therachon gets US FDA orphan drug status for apraglutide for short bowel syndrome treatment

Therachon AG, a clinical─stage biotechnology company focused on the discovery, development and commercialization of innovative treatments for serious rare conditions, announced that the US Food and Drug

Pacira Pharma phase 4 study of Exparel in patients undergoing C─section achieves primary endpoint with significant reductions in opioid consumption

Pacira Pharmaceuticals, announced that its phase 4 study of Exparel (bupivacaine liposome injectable suspension) in patients undergoing Cesarean section (C─section) achieved its primary endpoint with a

Baxter announces Sharesource remote patient management platform performs 5 million home dialysis treatments globally

Baxter International Inc, a global innovator in renal care, announced the Sharesource remote patient management platform has performed more than 5 million home peritoneal dialysis (PD) treatments globally.

Is ayurveda losing way to modern medicine?

Ayurveda, the Indian ethnomedicine, has gained substantial importance in recent times at international level.

Tab. Pheniramine

Tab. Pheniramine


In spite of several headwinds including intermittent warning letters by the US FDA even to major Indian companies, the Indian pharmaceutical companies and their subsidiaries have shown an impressive performance

Ironwood Pharma gets Chinese marketing approval for Linzess to treat irritable bowel syndrome with constipation

AstraZeneca announced that its partner Ironwood Pharmaceuticals, Inc has received marketing authorisation from the National Medical Products Administration (NMPA) for Linzess (linaclotide) in China for the

IPA─Karnataka to organise seminar on 'Recent developments in product development & tech transfer' on Feb 2

The Indian Pharmaceutical Association (IPA) Karnataka State Branch will organise a one─day seminar on 'Recent Developments in Pharmaceutical Product Development & Technology Transfer'. The day─long event will be

Tuesday 15th January 2019

Bristol─Myers receives European approval for Opdivo plus low dose Yervoy to treat patients with intermediate─ and advanced RCC

Bristol─Myers Squibb Company announced that the European Commission has approved the combination of Opdivo (nivolumab) 3 mg/kg plus Yervoy (ipilimumab) 1 mg/kg (low─dose) for the first─line treatment

Eisai to present abstracts from phase 3 REFLECT trial of Lenvima in unresectable HCC at 2019 Gastrointestinal Cancers Symposium

Eisai Inc. to present four abstracts at the 2019 Gastrointestinal Cancers Symposium, taking place in San Francisco from January 17─19, 2019. The presentations feature the latest data from post─hoc analyses of the pivotal

Ascletis and Alphamab sign licensing agreement for Anti─PD─L1 to treat hepatitis B and other viral diseases

Ascletis Pharma Inc and Suzhou Alphamab Co, Ltd. jointly announced that Ascletis' subsidiary and Alphamab have entered into a strategic collaboration and exclusive licensing agreement for anti─PD─L1 KN035 to

India facing knee arthritis epidemic, says Dr Vikram I Shah

More than 15 crore Indians suffer from knee problems, out of which about 4 crore patients need total knee replacement (TKR), imposing a huge health burden on the country. In contrast, in China, about 6.5 crore people

Indian pharma market growth at 9.8% in December 2018 to Rs.11,122 cr; full year 2018 IPM reaches at Rs.1,17,878 cr

Indian Pharmaceutical Market (IPM) has registered strong growth of 9.8% during the month of December 2018 to Rs.11,122 crore on account of higher volumes. Multinational companies achieved growth of 9% and

Monday 14th January 2019

AirPHX deploys non─thermal plasma technology to reduce HAI & GCBR risks in live hospitals

airPHX confirms successful results from deployment of patented non─thermal plasma technology in two live hospital environments. The deployments are in a Mid─Atlantic US hospital, and they include treating

Lineagen partners with PWNHealth to expand access to genetic testing solutions for autism & neurodevelopmental disorder communities

Lineagen, a leading provider of clinical genetic testing, is partnering with PWNHealth to expand access to its clinical genetic tests.

Lupus Research Alliance announces translational research grants to speed development of new treatments

Lupus Research Alliance with the latest round of its Target Identification in Lupus (TIL) grants recognized seven outstanding scientists from across the United States will receive awards worth up to US$ 600,000 for

KSRPA urges health ministry to allow registered pharmacists to dispense drugs during medical emergency

The Karnataka State Registered Pharmacists Association (KSRPA) has urged the Union health ministry to allow registered pharmacists to dispense drugs for common and minor ailments during medical

Saturday 12th January 2019

Olympus announces transformation plan to continue development as global medtech company

Olympus Corporation announced a comprehensive transformation programme to continue its development as a global medical technology (medtech) company and drive improved performance, accelerating value

Clarivate Analytics joins Accenture's open partner ecosystem to help speed up innovation in drug discovery & scientific research

Clarivate Analytics, the global leader in providing trusted insights and analytics to accelerate the pace of innovation, has joined Accenture's open partner ecosystem, which is designed to help independent software

Fujifilm introduces next generation Apollo X advanced mammalian expression system

Fujifilm Diosynth Biotechnologies (Fujifilm), a leading contract development and manufacturing organization (CDMO) with experience in the development and manufacture of recombinant biopharmaceuticals and

4,677 PMBJP Kendras functional in 35 states/UTs of the country by end of year 2018

Union minister for chemicals and fertilizers Mansukh Mandaviya has stated that the 'Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana' (PMBJP) has resulted in the saving of approximately Rs.1,668 crore to the citizens of country.

Friday 11th January 2019

Hetero launches generic lapatinib in India

Hetero, one of India's leading generic pharmaceutical companies and world's largest producer of anti─retroviral drugs, announces the launch of generic version of lapatinib (250 mg) tablets in India. The product is

Vast Therapeutics' drug candidate, BIOC51 is active against Bacillus anthracis, commonly known as anthrax

Vast Therapeutics, Inc., a preclinical stage pharmaceutical company delivering nitric oxide in a powder─based form, announced that the company's drug candidate, BIOC51, is active against Bacillus anthracis,

Agenus to leverage Selexis' modular SUREtechnology platform for rapid, stable, and cost─effective production of therapeutic proteins

Selexis SA, a pioneering life sciences company and a global leader in mammalian cell line generation technology, has signed additional commercial license agreements (CLAs) with Agenus Inc, an immuno─

Asuragen introduces AmplideX PCR/CE HTT kit to detect CAG trinucleotide repeats within the HTT gene

Asuragen, Inc., a molecular diagnostics company delivering easy─to─use products for complex testing in genetics and oncology, announced the launch of the AmplideX PCR/CE HTT Kit. This product is a simple,

Quick Search


News Quicklinks